LMAT 241115 125.00C (LMAT241115C125000) Stock Options, News & Quotes

US OptionsDetailed Quotes

LMAT241115C125000

Watchlist

0.20
0.000.00%

15min DelayTrading Oct 31 09:30 ET

0.00High0.00Low

Intraday

5D
Daily

News

Apple To Rally Around 16%? Here Are 10 Top Analyst Forecasts For Friday
Benzinga12:13 ET
Barrington Research Maintains Outperform on LeMaitre Vascular, Raises Price Target to $93
BenzingaNov 1 11:31 ET · Ratings
LeMaitre Vascular Analyst Ratings
BenzingaNov 1 11:29 ET · Ratings
A Quick Look at Today's Ratings for LeMaitre Vascular(LMAT.US), With a Forecast Between $93 to $100
Moomoo NewsNov 1 09:00 ET · Ratings
Express News | LeMaitre Vascular Inc : Stifel Raises Target Price to $100 From $95
ReutersNov 1 07:21 ET
LeMaitre Vascular, Inc. (LMAT) Q3 2024 Earnings Call Transcript Summary
moomoo AIOct 31 20:25 ET · Conference Call

Comments

Moomoo AI

Feb 9 06:29

The significant insider selling of LeMaitre Vascular shares, especially by the Chairman & CEO, and the absence of insider purchases, may worry shareholders. Yet, the high insider ownership could suggest the company operates in all shareholders' interest.

LeMaitre Vascular Insiders Sell US$5.3m Of Stock, Possibly Signalling Caution

Moomoo AI

Oct 27, 2023 06:06

High level of insider ownership suggests long-term benefit for company. Recent substantial insider selling at a higher price than current stock value might concern shareholders.

LeMaitre Vascular Insiders Sold US$1.3m Of Shares Suggesting Hesitancy

Moomoo AI

Oct 11, 2023 08:07

LeMaitre Vascular's short-term returns show decline but its growth reinvestment and increasing sales are encouraging. With a continuation in growth trends and a past record of 112% return over five years, the stock appears promising for long-term investors.

Capital Allocation Trends At LeMaitre Vascular (NASDAQ:LMAT) Aren't Ideal